Skip to Main Content

Paper Details

HER2-positive breast-cancer cell lines are sensitive to KDM5 inhibition: definition of a gene-expression model for the selection of sensitive cases.
Oncogene
20
2019
Author NameAffiliation
Kristian HelinUniversity of Copenhagen Ole Maaloes Vej 5
Kristian HelinThe Novo Nordisk Foundation for Stem Cell Biology, University of Copenhagen
  • 1 - 2

Datasets

Release 1.2